Skip to content

Efficacy of Bhringaraja Arka in the management of Neonatal Jaundice.

Efficacy of Bhringaraja Arka as an add-on to Standard Care in the management of Neonatal Jaundice - An open labelled randomized controlled clinical trail. - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/084172
Enrollment
40
Registered
2025-04-04
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K768- Other specified diseases of liver

Interventions

None listed

Sponsors

ITRA Jamnagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Neonates of either gender irrespective of caste and creed. Late preterm and term neonates with body weight more than 2500 g.

Exclusion criteria

Exclusion criteria: Neonates with birth Asphyxia Neonates having a 5 minute Apgar score of less than 7

Design outcomes

Primary

MeasureTime frame
Levels of TcB. (Daily - each 24hrs) Number of subjects required Phototherapy. (After treatment with 7days) Number of days/hours required for recovery from Neonatal Jaundice. (After treatment is less than 7days) Timepoint: Levels of TcB. (Daily each 24hrs) Number of subjects required Phototherapy. (After treatment within 7days) Number of days/hours required for recovery from Neonatal Jaundice. (After treatment is less than 7days)

Secondary

MeasureTime frame
Number of days required for phototherapy. (After treatment) Serum Bilirubin (Before and After treatment) Timepoint: 7days or until the remission of Jaundice

Countries

India

Contacts

Public ContactDr. Sagar M Bhinde

Institute of Teaching and Research in Ayurveda

sgrbhinde@itra.edu.in9662512158

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026